Mission
Lupus Therapeutics is the clinical research affiliate of the Lupus Research Alliance. As an organization, Lupus Therapeutics is on a mission to advance clinical development of new therapies through optimized clinical research and patient engagement so that the diverse lupus community has access to safe and effective treatments.
To do this, Lupus Therapeutics has four mission-aligned goals:
Foster open communication between biopharmaceutical companies and the community to ensure that people with all types of lupus remain front and center in all aspects of research
Mobilize biopharmaceutical companies, clinical investigators, and patients to help move research forward faster through LuCIN, a network of leading research institutions with more than 50 centers throughout North America
Co-create patient-centric programming with community partners to eliminate clinical trial access barriers and increase participation rates among diverse communities
Collaborate with biopharmaceutical companies to improve the clinical research process with a full suite of customized services aimed at advancing the drug development process